3Bohen WW. Scientific rationale for specific inhibition of COX -2[J]. J Rheumatol,1998,25(5) :2.
4Schenck P, Schneider S, Michlke S, et al. Synthesis and degradation of hyaluronate by synovia from patients with rheuma- toid arthritis[J]. Rheumatol,1995,22(2) :400.
5Neo H, Ishimara JI, Kurta K, et al. The effect of hyaluronic acid on experimental temporomandibular joint osteoarthrosis in the ship [ J ]. J Oral Maxill of Ac Sury, 1977,55 (10) : 1114.
7Kivitz AJ, Moskowitz RW, Woods E, et al. Comparative ef-ficacy and safety celecoxib vs nonsteroidal anti - inflammatory drugs for osteoarthritis and of celecoxib and naproxen in the treat-merit' of osteoarthritis of the hip [ J ]. J Int Med 1Res, 2001,29 ( 6 ) : 467.
8胥少汀 葛宝丰.实用骨科学[M].北京:人民军区出版社,2005.1198-1207.
9Lequesne M G, Mery C, Samson M,et al. Indexes of severityfor osteoarthritis of the hip and the knee. Validation-value incomparison with other assessment test [J]. Scand J RheumatolSuppl, 1987(65):85-89.
10Pel Mier J P,Mccollum R,Cloutier J M. Synthesis of metallopro-teases andinterleukin-6 (IL-6) in human osteoarthritis synovia membrance is all IL-l mediatedprocess[J].Rheumatol,2002,(Suppl):109.
